Details werden geladen...
VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister | The Manila Times
ZURICH, SWITZERLAND - July 10, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; 'VERAXA”), an emerging leader in designing novel cancer therapies, today announced the appointment of Carl von Halem as Interim Chief Financial Officer. He succeeds Torsten Bürgermeister. The company is currently in the final stages of discussions with a highly qualified successor who is expected to support VERAXA’s next phase of expansion and operational growth. The company will provide an update to the market in due course
Ähnliche Seiten
VERAXA Biotech AG: VERAXA Biotech AG Appoints Carl von Halem as Interim Chief Financial Officer and Successor to Torsten Bürgermeister
https://www.finanznachrichten.de/nachrichten-2026-07/68999972-veraxa-biotech-ag-veraxa-biotech-ag-appoints-carl-von-halem-as-interim-chief-financial-officer-and-successor-to-torsten-buergermeister-399.htm
Core AI Holdings Appoints Arie Goor as Chief Financial Officer | The Manila Times
https://www.manilatimes.net/2026/07/07/tmt-newswire/globenewswire/core-ai-holdings-appoints-arie-goor-as-chief-financial-officer/2379872Longeveron® Appoints Marie Washburn as Chief Financial Officer | The Manila Times
https://www.manilatimes.net/2026/07/07/tmt-newswire/globenewswire/longeveron-appoints-marie-washburn-as-chief-financial-officer/2379342
Croesus appoints Patrick Chamberland as Vice-President and Chief Financial Officer | The Manila Times
https://www.manilatimes.net/2026/06/05/tmt-newswire/globenewswire/croesus-appoints-patrick-chamberland-as-vice-president-and-chief-financial-officer/2359245Rani Therapeutics Appoints Nicholas Maestas as Chief Financial Officer | The Manila Times
https://www.manilatimes.net/2026/06/29/tmt-newswire/globenewswire/rani-therapeutics-appoints-nicholas-maestas-as-chief-financial-officer/2374813